SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-14-308346
Filing Date
2014-08-13
Accepted
2014-08-13 15:49:28
Documents
13
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-K d736246d10k.htm 10-K 1517379
2 EX-21.1 d736246dex211.htm EX-21.1 10582
3 EX-23.1 d736246dex231.htm EX-23.1 5114
4 EX-31.1 d736246dex311.htm EX-31.1 9145
5 EX-31.2 d736246dex312.htm EX-31.2 9125
6 EX-32 d736246dex32.htm EX-32 3836
13 GRAPHIC g736246g67p56.jpg GRAPHIC 38661
  Complete submission text file 0001193125-14-308346.txt   10681982

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT mygn-20140630.xml EX-101.INS 1758834
8 XBRL TAXONOMY EXTENSION SCHEMA mygn-20140630.xsd EX-101.SCH 75532
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mygn-20140630_cal.xml EX-101.CAL 127426
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mygn-20140630_def.xml EX-101.DEF 503200
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE mygn-20140630_lab.xml EX-101.LAB 631329
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mygn-20140630_pre.xml EX-101.PRE 593538
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26642 | Film No.: 141037414
SIC: 2835 In Vitro & In Vivo Diagnostic Substances